🇨🇦 Canada Country × Condition
ulcerative colitis Clinical Trials in Canada
Active clinical trials for ulcerative colitis with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇨🇦 Canada
Active Trials in Canada (5)
NCT06042387
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
Enrollment
150 pts
Country
🇨🇦 Canada
Mount Sinai Hospital, Canada
View Trial → NCT05784246 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
Enrollment
60 pts
Country
🇨🇦 Canada
Eli Lilly and Company
View Trial → NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Enrollment
300 pts
Country
🇨🇦 Canada
National Cancer Institute (NCI)
View Trial → NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Enrollment
980 pts
Country
🇨🇦 Canada
Sanofi
View Trial → NCT06696014
Recruiting
Mirikizumab Real World Protocol
Enrollment
100 pts
Country
🇨🇦 Canada
University of North Carolina, Chape...
View Trial → Frequently Asked Questions
How many ulcerative colitis clinical trials are active in Canada?
There are currently 5 active clinical trials for ulcerative colitis with sites in Canada, of which 5 are actively recruiting patients.
How can I join a ulcerative colitis clinical trial in Canada?
To join a ulcerative colitis clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ulcerative colitis trials in Canada?
Active ulcerative colitis trials in Canada span Phase 3, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.